News
12-05-2012, 03:08 AM
AstraZeneca today announced the presentation of important new data from studies of FASLODEX (fulvestrant) Injection at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium taking place from 4-8 December at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
More... (http://www.news-medical.net/news/20121205/New-data-from-AstraZenecas-FASLODEX-studies-on-breast-cancer-to-be-presented-at-SABSC.aspx)
More... (http://www.news-medical.net/news/20121205/New-data-from-AstraZenecas-FASLODEX-studies-on-breast-cancer-to-be-presented-at-SABSC.aspx)